• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, February 7, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Morris Animal Foundation study shows drug comes up short in osteoarthritis pain relief

Bioengineer by Bioengineer
May 2, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Morris Animal Foundation-funded researchers from the University of Georgia, have found that tramadol was ineffective in alleviating signs of pain associated with osteoarthritis in dogs. The research team published their results in the Journal of the American Veterinary Medical Association.

"The data shows conclusively that tramadol is not an effective drug in treating the pain associated with arthritis in the dog, despite its common recommendation," said Dr. Steven Budsberg, Professor of Surgery and Director of Clinical Research at the University of Georgia College of Veterinary Medicine. "This use of tramadol is a classic example of failing to acknowledge and control for bias when evaluating a potential treatment."

Osteoarthritis is a common and progressive condition of dogs, affecting approximately 14 million adult dogs in the United States alone. Osteoarthritis causes pain and discomfort, limiting mobility as well as negatively impacting the quality of life. Numerous options are available to treat osteoarthritis, with drug therapy to alleviate pain a cornerstone of treatment. However, there are still questions regarding which therapies are most effective.

The team at University of Georgia, led by Budsberg, studied the problem by comparing the commonly used medication tramadol against both placebo and non-steroidal anti-inflammatory drugs in client-owned dogs in a randomized, blinded, placebo and positive-controlled crossover study.

Dogs with osteoarthritis of the elbow or knee were assigned to receive each of three treatments in a random order. Each treatment arm lasted for 10 days. Improvement was measured using a battery of tests that evaluated a dog's gait and pain. The results showed no improvement when tramadol was given compared to either baseline or placebo. The study results highlight the need for carefully controlled studies when evaluating drug effectiveness.

"Recognition and alleviation of pain in animals has been a priority for Morris Animal Foundation since our founding," said Dr. Kelly Diehl, Senior Scientific and Communications Adviser at Morris Animal Foundation. "This study reinforces the need to carefully and systematically evaluate a pain medication's effectiveness before it becomes commonly prescribed, no matter what the species."

###

About Morris Animal Foundation

Morris Animal Foundation's mission is to bridge science and resources to advance the health of animals. Founded by a veterinarian in 1948, we fund and conduct critical health studies for the benefit of all animals. Learn more at morrisanimalfoundation.org.

Media Contact

Sean Andersen-Vie
[email protected]
720-639-3293
@morris_animal

http://www.morrisanimalfoundation.org

https://www.morrisanimalfoundation.org/article/morris-animal-foundation-study-shows-drug-comes-short-osteoarthritis-pain-relief

Related Journal Article

http://dx.doi.org/10.2460/javma.252.4.427

Share12Tweet7Share2ShareShareShare1

Related Posts

TPMT Expression Predictions Linked to Azathioprine Side Effects

February 7, 2026

Improving Dementia Care with Enhanced Activity Kits

February 7, 2026

Decoding Prostate Cancer Origins via snFLARE-seq, mxFRIZNGRND

February 7, 2026

Digital Health Perspectives from Baltic Sea Experts

February 7, 2026
Please login to join discussion

POPULAR NEWS

  • Robotic Ureteral Reconstruction: A Novel Approach

    Robotic Ureteral Reconstruction: A Novel Approach

    82 shares
    Share 33 Tweet 21
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    57 shares
    Share 23 Tweet 14
  • Breakthrough in RNA Research Accelerates Medical Innovations Timeline

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

TPMT Expression Predictions Linked to Azathioprine Side Effects

Improving Dementia Care with Enhanced Activity Kits

Decoding Prostate Cancer Origins via snFLARE-seq, mxFRIZNGRND

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 73 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.